0000899243-19-013262.txt : 20190513
0000899243-19-013262.hdr.sgml : 20190513
20190513170352
ACCESSION NUMBER: 0000899243-19-013262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190509
FILED AS OF DATE: 20190513
DATE AS OF CHANGE: 20190513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meeker David P
CENTRAL INDEX KEY: 0001385155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 19819224
MAIL ADDRESS:
STREET 1: C/O PENWEST PHARMACEUTICALS CO
STREET 2: 39 OLD RIDGEBURY ROAD SUITE 11
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-09
0
0001563880
Trevi Therapeutics, Inc.
TRVI
0001385155
Meeker David P
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN
CT
06510
1
0
1
0
Common Stock
2019-05-09
4
C
0
300536
A
300536
D
Common Stock
2019-05-09
4
C
0
27432
A
327968
I
By Trevi 2014 Irrevocable Trust
Common Stock
2019-05-09
4
C
0
13271
A
341239
I
By Spinnaker Trust as Trustee for Trevi 2014 Irrevocable Trust
Common Stock
2019-05-09
4
P
0
11250
10.00
A
352489
D
Series A Preferred Stock
2019-05-09
4
C
0
924880
0.00
D
Common Stock
128243
0
D
Series A Preferred Stock
2019-05-09
4
C
0
192000
0.00
D
Common Stock
27432
0
I
By Trevi 2014 Irrevocable Trust
Series A Preferred Stock
2019-05-09
4
C
0
95712
0.00
D
Common Stock
13271
0
I
By Spinnaker Trust as Trustee for Trevi 2014 Irrevocable Trust
Series B Preferred Stock
2019-05-09
4
C
0
869565
0.00
D
Common Stock
116375
0
D
Series C Preferred Stock
2019-05-09
4
C
0
478951
0.00
D
Common Stock
55918
0
D
On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
On May 9, 2019, the Series B Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
/s/ David P. Meeker
2019-05-09